Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

Table 2 Follow-up schedule

	Before Treatment	Years 3-5		Years 3-5
	Before Treatment	Every 3 months	Month 3, 6, 12, 18 and 24	Every 6 months
History and Physical	X	X		X
Baseline staging investigations (see text)	X
CT head, chest, abdomen, pelvis			X	X
Bone Scan			X	X
Toxicity Scoring		X		X
FACT-G QOL scoring	X	X		X

ISSN: 1471-2407